Histamine dihydrochloride and low-dose interleukin-2 has antileukemic efficacy in NPM1-mutated and myelomonocytic/monocytic acute myeloid leukemia

Antzeko izenburuak

• Histamine dihydrochloride and low-dose interleukin-2 has antileukemic efficacy in NPM1-mutated and myelomonocytic/monocytic acute myeloid leukemia
  nork: Malin S. Nilsson, et al.
  Argitaratua: (2024-06-01)
• Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells
  nork: Johan Aurelius, et al.
  Argitaratua: (2012-12-01)
• Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia
  nork: Hana Komic, et al.
  Argitaratua: (2024-08-01)
• Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma
  nork: Issdisai N, et al.
  Argitaratua: (2026-06-01)
• Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
  nork: Malin S. Nilsson, et al.
  Argitaratua: (2020-01-01)